Visualizaciones | |
---|---|
Bioequivalence risk assessment of oral formulations containing racemic ibuprofen through a chiral physiologically based pharmacokinetic model of ibuprofen enantiomers | 56 |
febrero 2024 | marzo 2024 | abril 2024 | mayo 2024 | junio 2024 | julio 2024 | agosto 2024 | |
---|---|---|---|---|---|---|---|
Bioequivalence risk assessment of oral formulations containing racemic ibuprofen through a chiral physiologically based pharmacokinetic model of ibuprofen enantiomers | 0 | 0 | 0 | 0 | 0 | 52 | 4 |
Visualizaciones | |
---|---|
Reig-LopezM Cuquerella-GilabertBandin-Vilar - Bioequivalence risk assessment of oral formulations....pdf | 7 |
Visualizaciones | |
---|---|
Estados Unidos | 29 |
China | 9 |
Francia | 5 |
Alemania | 3 |
Irlanda | 3 |
Bulgaria | 1 |
Suiza | 1 |
Corea del Sur | 1 |
Lituania | 1 |
Noruega | 1 |
Visualizaciones | |
---|---|
Houston | 13 |
Guangzhou | 3 |
Ann Arbor | 2 |
Ashburn | 2 |
Durham | 2 |
Basking Ridge | 1 |
Buffalo | 1 |
Menlo Park | 1 |
Newark | 1 |
Odessa | 1 |